Preface
Prostate cancer screening and active surveillance in the Western world
Translational Andrology and Urology
2018;
7
(1)
:1-2
.
(23 January 2018)
How to improve duration and quality of life in men?
Translational Andrology and Urology
2018;
7
(1)
:3
.
(23 January 2018)
Perspective
Screening for prostate cancer: are organized screening programs necessary?
Translational Andrology and Urology
2018;
7
(1)
:4-11
.
(23 January 2018)
Review Article
Prostate cancer screening: what can we learn from randomised trials?
Translational Andrology and Urology
2018;
7
(1)
:12-17
.
(23 January 2018)
Original Article
Head-to-head comparison of prostate cancer risk calculators predicting biopsy outcome
Translational Andrology and Urology
2018;
7
(1)
:18-26
.
(23 January 2018)
Multivariable risk-based patient selection for prostate biopsy in a primary health care setting: referral rate and biopsy results from a urology outpatient clinic
Translational Andrology and Urology
2018;
7
(1)
:27-33
.
(23 January 2018)
Review Article
Prostate cancer screening—when to start and how to screen?
Translational Andrology and Urology
2018;
7
(1)
:34-45
.
(23 January 2018)
Stopping screening, when and how?
Translational Andrology and Urology
2018;
7
(1)
:46-53
.
(23 January 2018)
Original Article
What is an acceptable false negative rate in the detection of prostate cancer?
Translational Andrology and Urology
2018;
7
(1)
:54-60
.
(23 January 2018)
Review Article
Men with a susceptibility to prostate cancer and the role of genetic based screening
Translational Andrology and Urology
2018;
7
(1)
:61-69
.
(23 January 2018)
MRI in early prostate cancer detection: how to manage indeterminate or equivocal PI-RADS 3 lesions?
Translational Andrology and Urology
2018;
7
(1)
:70-82
.
(23 January 2018)
Review Article
Active surveillance for prostate cancer: a systematic review of contemporary worldwide practices
Translational Andrology and Urology
2018;
7
(1)
:83-97
.
(23 January 2018)
Original Article
Can active surveillance really reduce the harms of overdiagnosing prostate cancer? A reflection of real life clinical practice in the PRIAS study
Translational Andrology and Urology
2018;
7
(1)
:98-105
.
(23 January 2018)
Review Article
Active surveillance: a review of risk-based, dynamic monitoring
Translational Andrology and Urology
2018;
7
(1)
:106-115
.
(23 January 2018)
Magnetic resonance imaging in active surveillance—a modern approach
Translational Andrology and Urology
2018;
7
(1)
:116-131
.
(23 January 2018)
Original Article
Reduction of MRI-targeted biopsies in men with low-risk prostate cancer on active surveillance by stratifying to PI-RADS and PSAdensity, with different thresholds for significant disease
Translational Andrology and Urology
2018;
7
(1)
:132-144
.
(23 January 2018)
Review Article
On cribriform prostate cancer
Translational Andrology and Urology
2018;
7
(1)
:145-154
.
(23 January 2018)
Biomarkers in active surveillance
Translational Andrology and Urology
2018;
7
(1)
:155-159
.
(23 January 2018)
Quality of life in active surveillance and the associations with decision-making—a literature review
Translational Andrology and Urology
2018;
7
(1)
:160-169
.
(23 January 2018)
eHealth and mHealth in prostate cancer detection and active surveillance
Translational Andrology and Urology
2018;
7
(1)
:170-181
.
(23 January 2018)
Being on active surveillance: the patient perspective
Translational Andrology and Urology
2018;
7
(1)
:182-187
.
(23 January 2018)
The future of prostate cancer research: bringing data together, looking back and forward
Translational Andrology and Urology
2018;
7
(1)
:188-194
.
(23 January 2018)
Disclosure:
The focused issue “Prostate Cancer Screening and Active Surveillance in the Western World” was commissioned by the editorial office, Translational Andrology and Urology without any sponsorship or funding. Monique J. Roobol served as the unpaid Guest Editor for the focused issue.